Island
Island offers an enterprise browser platform that integrates security, access control, and AI-powered productivity tools directly into the browser. The product aims to address common enterprise challenges such as secure access, data protection, and workflow visibility without requiring additional layers of infrastructure.
Public-source profile · Company ownership not verified. Sources & corrections
The short feature · 2 min read
Island, at a glance
Built for · Enterprise IT and security teams managing remote workforces, BYOD policies, third-party contractors, and AI-driven workflows.
Based on company material. Product claims are attributed to the company.
- 01
The problem
Enterprises face fragmented security and access controls when managing remote workforces, BYOD devices, and third-party contractors. Traditional solutions require separate tools for zero-trust network access (ZTNA), data loss prevention (DLP), and browser security, leading to operational complexity and visibility gaps.
Sources [1]
- 02
The product approach
Island’s enterprise browser embeds security, access controls, and AI productivity features directly into the browser, eliminating the need for separate tools. It provides a unified interface for enforcing DLP, ZTNA, and safe browsing while enabling visibility into user activity and third-party access.
Sources [1]
- 03
What stands out
Unlike traditional security tools that bolt on protections, Island integrates controls into the browser itself, claiming to reduce friction for end users while maintaining security. For example, it enables BYOD access with built-in protections rather than requiring virtual desktop infrastructure (VDI) or separate security layers.
Sources [1]
What could be hard to replicate?
A useful product is not automatically a moat. These mechanisms need evidence of a lasting advantage.
Switching costs
Company claimIsland claims its browser-native architecture reduces switching costs for enterprises by consolidating security, access, and productivity tools into a single platform. This integration may discourage customers from adopting piecemeal alternatives.
Mechanism → evidence check
What value would a customer lose when changing products?
Sources [1]
Operations & scale
Company claimThe platform’s built-in controls for ZTNA, DLP, and AI productivity could create operational efficiencies for IT teams, as they avoid managing multiple vendors or tools.
Mechanism → evidence check
Does operating experience create a sustained cost or execution advantage?
Sources [1]
The question to watch
While Island claims to simplify enterprise workflows by integrating security and productivity tools into the browser, independent evidence is limited on whether this approach reduces operational overhead or improves security outcomes compared to traditional layered solutions.
Explore the evidence · 1 source
- [1] Island company website
Company material · checked 5/10/2026
Govern human and AI workflows with Island’s Enterprise Agentic Control Plane. Streamline ZTNA, enforce browser DLP, and optimize digital experiences. Island | The Enterprise Agentic…
About
Govern human and AI workflows with Island’s Enterprise Agentic Control Plane. Streamline ZTNA, enforce browser DLP, and optimize digital experiences.
Founders
- Mike Fey
- Dan Amiga
Profile sources, ownership & corrections
Company ownership is not verified
This profile was compiled from public sources and hasn't been verified by Island. Claim it to correct the details, add your team and funding history, and request review of your company information.
Compiled from news coverage, the company's own website.
Similar startups
AI3D Studio — ai3d.studio
AI3D Studio is a browser-based platform that converts 2D inputs—such as photos, text prompts, sketches.
SignSplit is a platform designed to allow individuals and institutions to manage their data, work, and likeness by enabling protection, licensing.
Decart is an AI lab developing real-time world models designed to operate at millisecond latency.
Isomorphic Labs is a company applying artificial intelligence to drug discovery.